Wonder if that's milford dumping still. Might not be as bad as it looks... in which case, that's a buying opportunity. Of course, it's all guesses this side of the announcement
Printable View
Wonder if that's milford dumping still. Might not be as bad as it looks... in which case, that's a buying opportunity. Of course, it's all guesses this side of the announcement
OCA market cap up 30% since listing on 8/5/17
ARV market cap up 35% since 8/5/17
Good ole ARV eh
All of the comparisons can be a bit meaningless as depending on the start date different shares can look good.
Each of us will have different returns depending when and how much we have invested. The talk of ARV being such a dog doesn't ring true for me - it has done better than OCA.
I'm spread (unevenly) across the sector. My returns (dividends included) for the last year:
ARV: 8.71%
MET: -15.24%
OCA: -0.08%
RYM: -1.77%
SUM: 7.42%
With OCA I have bought over the last year, the others have mostly just been sitting there. OCA's returns for me are suffering mainly because I bought chunks at 113c and 114c.
MET is definitely the dog. ARV on the other hand I am quite happy with.
I hope that all the positive talk about OCA eventually comes to something because they are overweight in my portfolio at present.
Directors buying on market, a good sign.
tj - Been too busy, have a look back, you'll see ARV did a big capital raise just over a year ago.
Two more directors bought on market, nice to see directors are keep topping up
Elizabeth Coutts - 50000 volumes
Kerry Prendergast - 75000 volumes